CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
Brunangelo Falini(University of Perugia), Stefano Pileri(European Institute of Oncology), Giovanni Pizzolo(Istituto di Ematologia di Bologna), Horst Dürkop(Istituto di Ematologia di Bologna), Leonardo Flenghi(Istituto di Ematologia di Bologna), Fiorenzo Stirpe(Istituto di Ematologia di Bologna), MF Martelli(Istituto di Ematologia di Bologna), H Stein(Istituto di Ematologia di Bologna)
Cited by 444Open Access
Abstract
THE INITIAL description of the Ki-l monoclonal antibody (MoAb) in 1982,' there has been an overwhelming flood of information concerning the Hodgkm's disease @)associated molecule CD30. In a diagnostic point of view, the Ki-l antibody enabled in 1985' the identification of a new category of non-Hodgkn's lymphomas designated as Ki"D30 anaplastic large cell lymphoma (ALCL).'
Related Papers
No related papers found
Powered by citation graph analysis